TRENT W. NICHOLS Jr., M.D.
Cimetidine, a histamine 2 (H-2) receptor antagonist of acid secretion, is a popular and well-accepted treatment. Its therapeutic efficacy in gastric ulceration (1), reflux esophagitis (2), and anastomotic ulceration after gastric surgery (3) has been documented. Gastric phytobezoar formation during cimetidine therapy was previously reported in a patient with peptic esophageal ulceration (4). Since then three additional patients have been seen in whom phytobezoars developed during cimetidine therapy; they are the subjects of this report.
Patient 1: A previously described (4) 55-year-old edentulous white woman with an endoscopically proven esophageal ulceration developed a gastric phytobezoar 14 days after treatment with
NICHOLS TW. Phytobezoar Formation: A New Complication of Cimetidine Therapy. Ann Intern Med. ;95:70. doi: 10.7326/0003-4819-95-1-70
Download citation file:
Published: Ann Intern Med. 1981;95(1):70.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use